Skip to main navigation
Skip to search
Skip to main content
Northwestern Scholars Home
Help & FAQ
Home
Experts
Organizations
Research Output
Grants
Core Facilities
Research Data
Search by expertise, name or affiliation
Positioning biologic agents in the treatment of Crohn's disease
Stephen B. Hanauer
Medicine, Gastroenterology Division
Research output
:
Contribution to journal
›
Review article
›
peer-review
18
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Positioning biologic agents in the treatment of Crohn's disease'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Crohn's Disease
100%
Biological Agents
100%
Patient Selection
50%
Biologic Therapy
50%
Tumor Necrosis Factor-α
25%
Immunosuppressive Therapy
25%
Targeted Tumor
25%
Surgical Resection
25%
Mechanism of Action
25%
Poor Prognosis
25%
Combination Therapy
25%
Aggressive Interventions
25%
Integrin
25%
Natural History
25%
Conventional Therapy
25%
Progressive Course
25%
Response Predictors
25%
Treatment Algorithm
25%
Refractory Disease
25%
Combined Intervention
25%
Risk-benefit
25%
Corticosteroids
25%
Multiple Courses
25%
Individual Agent
25%
Fistulization
25%
Long-term Maintenance Therapy
25%
Medicine and Dentistry
Biological Product
100%
Crohn's Disease
100%
Diseases
50%
Biological Therapy
50%
Combination Therapy
25%
Tumor Necrosis Factor
25%
Maintenance Therapy
25%
Surgery
25%
Integrin
25%
Immunosuppressant
25%